Charles Schwab Investment Management Inc Soma Logic, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$1.76 - $2.83 $5,295 - $8,515	-3,009 Reduced 0.25%	1,219,760 $3.09 Million
Q3 2023 Nov 08, 2023	BUY	$1.99 - $2.45 $123,610 - $152,184	62,116 Added 5.35%	1,222,769 $2.92 Million
Q2 2023 Aug 09, 2023	BUY	$2.1 - $3.36 $71,288 - $114,061	33,947 Added 3.01%	1,160,653 $2.68 Million
Q1 2023 May 11, 2023	BUY	$2.13 - $3.6 $27,745 - $46,893	13,026 Added 1.17%	1,126,706 $2.87 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $59,704 - $101,060	29,124 Added 2.69%	1,113,680 $2.8 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $31,497 - $273,478	49,996 Added 4.83%	1,084,556 $3.15 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $1.35 Million - $2.61 Million	315,853 Added 43.95%	1,034,560 $4.68 Million
Q1 2022 May 13, 2022	BUY	$7.07 - $11.62 $186,874 - $307,139	26,432 Added 3.82%	718,707 $5.77 Million
Q4 2021 Feb 11, 2022	BUY	$10.49 - $14.28 $7.26 Million - $9.89 Million	692,275 New	692,275 $8.06 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.